SEK 98.05
(1.24%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 2.28 Billion SEK | 0.2% |
2022 | 2.03 Billion SEK | 24.02% |
2021 | 1.65 Billion SEK | 2.47% |
2020 | 1.61 Billion SEK | 17.7% |
2019 | 1.37 Billion SEK | 144.34% |
2018 | 602 Million SEK | 18.61% |
2017 | 571 Million SEK | 4.05% |
2016 | 374 Million SEK | 42.77% |
2015 | 330 Million SEK | 86.23% |
2014 | 221 Million SEK | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | 593 Million SEK | 19.8% |
2024 Q2 | 547 Million SEK | -7.76% |
2023 Q4 | 495 Million SEK | -28.57% |
2023 Q3 | 693 Million SEK | 42.89% |
2023 Q1 | 510 Million SEK | 26.87% |
2023 Q2 | 485 Million SEK | -4.9% |
2023 FY | - SEK | 0.2% |
2022 Q2 | 511 Million SEK | 13.3% |
2022 FY | - SEK | 24.02% |
2022 Q4 | 402 Million SEK | -37.19% |
2022 Q3 | 640 Million SEK | 25.24% |
2022 Q1 | 451 Million SEK | 44.55% |
2021 FY | - SEK | 2.47% |
2021 Q1 | 358 Million SEK | -1.65% |
2021 Q2 | 368 Million SEK | 2.79% |
2021 Q3 | 578 Million SEK | 57.07% |
2021 Q4 | 312 Million SEK | -46.02% |
2020 Q1 | 362 Million SEK | 26.13% |
2020 Q2 | 358 Million SEK | -1.1% |
2020 Q4 | 364 Million SEK | -26.17% |
2020 Q3 | 493 Million SEK | 37.71% |
2020 FY | - SEK | 17.7% |
2019 FY | - SEK | 144.34% |
2019 Q4 | 287 Million SEK | -43.06% |
2019 Q3 | 504 Million SEK | 77.46% |
2019 Q2 | 284 Million SEK | 5.97% |
2019 Q1 | 268 Million SEK | 272.22% |
2018 FY | - SEK | 18.61% |
2018 Q4 | 72 Million SEK | -67.71% |
2018 Q3 | 223 Million SEK | 71.54% |
2018 Q2 | 130 Million SEK | 5.69% |
2018 Q1 | 123 Million SEK | 161.7% |
2017 Q3 | 198 Million SEK | 69.23% |
2017 FY | - SEK | 4.05% |
2017 Q4 | 47 Million SEK | -76.26% |
2017 Q1 | 99 Million SEK | -15.38% |
2017 Q2 | 117 Million SEK | 18.18% |
2016 Q1 | 71 Million SEK | 0.0% |
2016 FY | - SEK | 42.77% |
2016 Q4 | 117 Million SEK | -33.14% |
2016 Q3 | 175 Million SEK | 118.75% |
2016 Q2 | 80 Million SEK | 12.68% |
2015 FY | - SEK | 86.23% |
2014 FY | - SEK | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Attendo AB (publ) | 3.11 Billion SEK | 26.774% |
Humana AB (publ) | 457 Million SEK | -399.125% |
ProstaLund AB (publ) | -16.57 Million SEK | 13864.181% |